Big Pharma's Ethical Dilemma: Should They Keep Selling to Russia?

Tadhg Ó Laoghaire, a researcher in economic ethics at the University of Gothenburg, Sweden, echoes Gillard: “They don’t have legal obligations to continue to provide goods to people.” But if they are not technically legally obliged, it’s still the moral thing to do, he continues. Pharmaceutical companies play a very niche role—“it’s not like someone else can just step in and fill these human rights.” If they choose to supply essential pharmaceutical goods to Russia, and then pull them away, that’s not just letting human rights violations happen, says Ó Laoghaire: “In a very real sense, they’re instigating those violations.”

But not everyone thinks the industry has watertight immunity to

→ Continue reading at Wired - Science

More from author

Related posts


Latest posts

Campbell: Firefighters battle blaze sparked at three-story commercial building

Firefighters responded to a report of a fire at a commercial building Friday morning in Campbell, according to authorities. (Santa Clara...

Hotline mailbag: Merger options for the Pac-12 and Big 12, SEC poaching possibilities, Arizona recruiting, Daniels to OSU(?) and more

The Hotline mailbag is published each Friday. Send questions to [email protected] or hit me on Twitter: @WilnerHotline. Due to volume — and in some cases, the...

How hackers, Arnold Schwarzenegger and the State Department are trying to pierce Putin’s digital Iron Curtain

By Sean Lyngaas, Kylie Atwood and Brian Fung | CNNThe information campaign over Russia’s invasion of Ukraine is in full swing as a wide...